GlycoMimetics Inc
Biotechnology
Healthcare
GLYC
64.28 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.32
52 week high
4.05
high
2.72
52 week low
1.32
previous Close
2.36
P/E ratio
market cap
105 M
div yield
0
net incoming
-8.26 M
15.53 %
net profit margin
-825891200.00 %
0.00 %
operating incoming
-8.93 M
18.38 %
net change in cash
-6.97 M
-140.66 %
cash on hand
58.04 M
-10.72 %
top